Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Comvita Limited Director's Dealing 2019

Jun 21, 2019

66182_rns_2019-06-21_18492f36-50f2-4111-a3b0-ea7e85778ad5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [91 x 25] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:

==> picture [218 x 84] intentionally omitted <==

Comvita Limited 21-Jun-19 22-May-19

Director or senior manager giving disclosure

Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

Neil John Craig Comvita Limited n/a Company Chair

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): Registered holder(s) once transfers are registered:

Ordinary Shares Beneficial owner of the shares 9,960 Neil John Craig - Start Scheme A/C; 500,000 Neil John Craig - Custodial Services Ltd; 11,098 Neil John Craig - Start Scheme A/C; 75,000 Sheryl Denise Tebbutt (Partner) - Custodial Services Ltd; 25,000 Anna Beth Craig (Daughter) - Custodial Services Ltd; 420,000 Neil John Craig, Sheryl Denise Tebbutt, Sharp Tudhope Trustee Services No 27 Ltd for Eaglesham Trust - Custodial Services Ltd Neil John Craig - Start Scheme A/c Neil John Craig - Start Scheme A/c

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related:

If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):

1 20-Jun-19 1,138 ordinary shares acquired pursuant to a non-discretionary fixed trading plan, to which shares will be acquired on a monthly basis without interruption over the next 12 months. This is the second acquisition of shares pursuant to the fixed trading plan. N/A $3,936 1

No N/A N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

21-Jun-19

==> picture [49 x 45] intentionally omitted <==

==> picture [91 x 25] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Comvita Limited
Date this disclosure made: 21-Jun-19
Date of last disclosure: 22-May-19
Director or senior manager giving disclosure
Full name(s): Christine MaryFleury
Name of listed issuer: Comvita Limited
Name of related body corporate (if applicable): n/a
Position held in listed issuer: Board Secretary
Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Ordinary Shares
Nature of the affected relevant interest(s): Craigs Start Scheme A/C - registered holder
For that relevant interest-
Number held in class before acquisition or disposal: Craigs Start Scheme A/C - 4,493
Tutamai Trust - 110,000
Number held in class after acquisition or disposal: Craigs Start Scheme A/C - 5,545
Tutamai Trust-110,000
Current registered holder(s): Christine MaryFleury
Registered holder(s)once transfers are registered: Christine MaryFleury
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 2
Details of transactions requiring disclosure-
Date of transaction: Various
Nature of transaction: 573 ordinary shares acquired pursuant to a non-
discretionary fixed trading plan, to which shares
will be acquired on a monthly basis without
interruption over the next 12 months. This is
the first acquisition of shares pursuant to the
fixed trading plan.
479 ordinary shares acquired through Craigs
Start SchemeA/c.
Name of any other party or parties to the transaction (if known): n/a
The consideration, expressed in New Zealand dollars, paid or received for the acquisition $3,973
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value,describe the consideration:
Number of financial products to which the transaction related: 1
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period: No
Whether prior written clearance was provided to allow the acquisition or disposal to n/a
proceed duringthe closedperiod:
Date of the prior written clearance (if any): n/a
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons for
whom it is made.
Signature of director or officer:
Date of signature: 21-Jun-19